The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable interest within the healthcare community. This novel dual GIP and GLP-1 receptor medication seems to provide significant improvements in weight reduction compared to previous therapies. Preliminary clinical trials have demonstrated significant declines in body fat pe… Read More